These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 26285176)

  • 1. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
    Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
    Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of AMPK activation in the inhibition of hepatic gluconeogenesis by Ficus carica leaf extract in diabetic mice and HepG2 cells.
    Zhang Y; Chen J; Zeng Y; Huang D; Xu Q
    Biomed Pharmacother; 2019 Jan; 109():188-194. PubMed ID: 30396076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis.
    Li W; Zhang M; Gu J; Meng ZJ; Zhao LC; Zheng YN; Chen L; Yang GL
    Fitoterapia; 2012 Jan; 83(1):192-8. PubMed ID: 22056666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
    Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
    Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells.
    Yuan HD; Piao GC
    Biosci Biotechnol Biochem; 2011; 75(6):1079-84. PubMed ID: 21670525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
    Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells.
    Yuan HD; Kim DY; Quan HY; Kim SJ; Jung MS; Chung SH
    Chem Biol Interact; 2012 Jan; 195(1):35-42. PubMed ID: 22062806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
    Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
    Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice.
    Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH
    Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells.
    Kim SJ; Yuan HD; Chung SH
    Biol Pharm Bull; 2010; 33(2):325-8. PubMed ID: 20118562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
    Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
    J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Phloroglucinol, A Component of Ecklonia cava Extract, on Hepatic Glucose Production.
    Yoon JY; Choi H; Jun HS
    Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28379184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entada phaseoloides extract suppresses hepatic gluconeogenesis via activation of the AMPK signaling pathway.
    Zheng T; Hao X; Wang Q; Chen L; Jin S; Bian F
    J Ethnopharmacol; 2016 Dec; 193():691-699. PubMed ID: 27742409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antidiabetic effect of ginsenoside Rb2 via activation of AMPK.
    Lee KT; Jung TW; Lee HJ; Kim SG; Shin YS; Whang WK
    Arch Pharm Res; 2011 Jul; 34(7):1201-8. PubMed ID: 21811928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
    Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
    PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
    Liu Y; Deng J; Fan D
    Food Funct; 2019 May; 10(5):2538-2551. PubMed ID: 30993294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis.
    Meng F; Su X; Li W; Zheng Y
    Exp Ther Med; 2017 May; 13(5):2551-2557. PubMed ID: 28565878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geniposide Suppresses Hepatic Glucose Production via AMPK in HepG2 Cells.
    Guo L; Zheng X; Liu J; Yin Z
    Biol Pharm Bull; 2016; 39(4):484-91. PubMed ID: 26830672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions.
    Aatsinki SM; Buler M; Salomäki H; Koulu M; Pavek P; Hakkola J
    Br J Pharmacol; 2014 May; 171(9):2351-63. PubMed ID: 24428821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.